Last reviewed · How we verify

NCT03178175

Acupuncture for Management of Balance Impairment in Patients With Parkinson's Disease

Terminated NA Last updated 1 March 2019
What this trial tests

NA trial testing Acupuncture in Parkinson Disease in 4 participants. Terminated before completion.

Timeline
29 December 2016
Primary endpoint
1 December 2018
11 December 2018

Quick facts

Lead sponsorChang Bing Show Chwan Memorial Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment4
Start date29 December 2016
Primary completion1 December 2018
Estimated completion11 December 2018
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chang Bing Show Chwan Memorial Hospital

Who can join

Adults 50 to 75, any sex, with Parkinson Disease or Acupuncture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This plan is to evaluate the effectiveness of scalp acupuncture, a modern acupuncture technique specialized to neurological disorders, in managing motor function and body balance for PD patients. This is a randomized, controlled, single-blind clinical trial.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. News from the Field
    · 2017

Verify or expand the search:

Other trials of Acupuncture

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Chang Bing Show Chwan Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03178175.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing